General Information of the Cell Line
Cell Line ID
CL000323
Cell Line Name
LoVo
Synonyms
LOVO
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0399
Tissue Information
Lymph node
Disease
Colon adenocarcinoma (NCIt: C4349)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00922, Epidermal growth factor receptor
Compound ID Compound Name Compound Formula
CP0509684
N-[2-[[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]methyl]phenyl]prop-2-enamide
   Show/Hide
C30H31N9O
 1
1
EC50 = 420 nM
   TI
   LI
   LO
   TS
CP0033646
AZD-9291
   Show/Hide
C28H33N7O2
 1
1
EC50 = 480 nM
   TI
   LI
   LO
   TS
CP0462444
N-[3-[2-[3-amino-6-[1-(1-propan-2-ylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C31H33N9O
 1
1
EC50 = 760 nM
   TI
   LI
   LO
   TS
CP0472275
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C29H29N9O
 1
1
EC50 = 980 nM
   TI
   LI
   LO
   TS
CP0445078
N-[3-[2-[3-amino-6-(1-methylpyrazol-4-yl)pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C24H20N8O
 1
1
EC50 = 1070 nM
   TI
   LI
   LO
   TS
CP0390865
N-[3-[2-[3-amino-6-[1-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C32H34N10O2
 1
1
EC50 = 1140 nM
   TI
   LI
   LO
   TS
CP0403145
N-[3-[2-[3-amino-6-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C30H31N9O
 1
1
EC50 = 1960 nM
   TI
   LI
   LO
   TS
CP0386432
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]-2-fluorophenyl]prop-2-enamide
   Show/Hide
C29H28FN9O
 1
1
EC50 = 2060 nM
   TI
   LI
   LO
   TS
CP0466881
N-[3-[2-[3-amino-6-[1-(2-hydroxyethyl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C25H22N8O2
 1
1
EC50 = 2250 nM
   TI
   LI
   LO
   TS
CP0474061
N-[3-[2-[3-amino-6-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C30H32N10O
 1
1
EC50 = 2310 nM
   TI
   LI
   LO
   TS
CP0556454
N-[3-[2-[3-amino-6-[1-[1-(2-hydroxyacetyl)piperidin-4-yl]pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C30H29N9O3
 1
1
EC50 = 3000 nM
   TI
   LI
   LO
   TS
CP0474062
N-[4-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C29H29N9O
 1
1
EC50 = 3380 nM
   TI
   LI
   LO
   TS
CP0386433
N-[3-[2-[6-[1-(1-acetylpiperidin-4-yl)pyrazol-4-yl]-3-aminopyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C30H29N9O2
 1
1
EC50 = 3510 nM
   TI
   LI
   LO
   TS
CP0445081
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]-4-fluorophenyl]prop-2-enamide
   Show/Hide
C29H28FN9O
 1
1
EC50 = 4390 nM
   TI
   LI
   LO
   TS
CP0466880
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]imidazo[4,5-c]pyridin-1-yl]phenyl]prop-2-enamide
   Show/Hide
C28H28N10O
 1
1
EC50 = 4390 nM
   TI
   LI
   LO
   TS
CP0556453
N-[3-[2-[3-amino-6-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C29H29N9O2
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0542299
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]-N-methylprop-2-enamide
   Show/Hide
C30H31N9O
 1
1
EC50 = 10900 nM
   TI
   LI
   LO
   TS
CP0542298
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]imidazo[4,5-c]pyridin-3-yl]phenyl]prop-2-enamide
   Show/Hide
C28H28N10O
 1
1
EC50 > 15000 nM
   TI
   LI
   LO
   TS
CP0403256
N-[5-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]-2-methoxyphenyl]prop-2-enamide
   Show/Hide
C30H31N9O2
 1
1
EC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0390850
N-[3-[[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]methyl]phenyl]prop-2-enamide
   Show/Hide
C30H31N9O
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0386431
N-[4-[[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]methyl]phenyl]prop-2-enamide
   Show/Hide
C30H31N9O
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0468764
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]-2-methylprop-2-enamide
   Show/Hide
C30H31N9O
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0468765
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]acetamide
   Show/Hide
C28H29N9O
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0153482
DACOMITINIB
   Show/Hide
C24H25ClFN5O2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0053637
(S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
   Show/Hide
C24H25ClFN5O3
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0036082
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C22H24ClFN4O3
 1
1
IC50 = 62 nM
   TI
   LI
   LO
   TS
CP0037987
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
   Show/Hide
C22H23N3O4
 1
1
IC50 = 77 nM
   TI
   LI
   LO
   TS
CP0465796
N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide
   Show/Hide
C22H18ClN5O2
 1
1
IC50 = 550 nM
   TI
   LI
   LO
   TS
CP0461892
N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-2-(4-methylpiperazin-1-yl)phenyl]prop-2-enamide
   Show/Hide
C27H28ClN7O2
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0059062
N-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide
   Show/Hide
C25H27ClN6O3
 1
1
IC50 = 1180 nM
   TI
   LI
   LO
   TS
CP0124322
N-[5-[[4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-2-(4-methylpiperazin-1-yl)phenyl]prop-2-enamide
   Show/Hide
C27H29N7O2
 2
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
2
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0391959
(E)-N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]-4-(dimethylamino)but-2-enamide
   Show/Hide
C25H25ClN6O2
 1
1
IC50 = 1550 nM
   TI
   LI
   LO
   TS
CP0404048
N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
   Show/Hide
C21H16ClN5O
 1
1
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0258411
N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
   Show/Hide
C27H30ClN7O2
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0051362
N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxy-2-(4-methylpiperazin-1-yl)phenyl]prop-2-enamide
   Show/Hide
C26H27ClN8O2
 1
1
IC50 = 12000 nM
   TI
   LI
   LO
   TS
CP0491725
N-[3-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]prop-2-enamide
   Show/Hide
C21H17ClN6O2
 1
1
IC50 = 12800 nM
   TI
   LI
   LO
   TS
CP0389113
N-[4-methoxy-2-(4-methylpiperazin-1-yl)-5-[(4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]prop-2-enamide
   Show/Hide
C26H28N8O2
 1
1
IC50 = 19000 nM
   TI
   LI
   LO
   TS
CP0432326
(E)-4-(dimethylamino)-N-[3-[(5-fluoro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]but-2-enamide
   Show/Hide
C24H24FN7O2
 1
1
IC50 = 19000 nM
   TI
   LI
   LO
   TS
CP0426650
(E)-4-(dimethylamino)-N-[4-methoxy-3-[(4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]but-2-enamide
   Show/Hide
C24H25N7O2
 1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0072400
(E)-N-[3-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]-4-(dimethylamino)but-2-enamide
   Show/Hide
C24H24ClN7O2
 2
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
2
IC50 = 23000 nM
   TI
   LI
   LO
   TS
CP0456898
(E)-4-(dimethylamino)-N-[4-methoxy-3-[(5-methyl-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]but-2-enamide
   Show/Hide
C25H27N7O2
 1
1
IC50 = 24000 nM
   TI
   LI
   LO
   TS
CP0389114
(E)-4-(dimethylamino)-N-[4-methoxy-3-[(5-methylsulfinyl-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]but-2-enamide
   Show/Hide
C25H27N7O3S
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0391960
1-[6-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-5-methoxy-2,3-dihydroindol-1-yl]prop-2-en-1-one
   Show/Hide
C24H20ClN5O2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0391961
N-[4-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
   Show/Hide
C21H16ClN5O
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0408469
N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]-2-cyanoacetamide
   Show/Hide
C22H17ClN6O2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0362793
N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide
   Show/Hide
C27H31N7O2
 1
1
IC50 = 33000 nM
   TI
   LI
   LO
   TS
CP0091599
N-[5-[[5-cyano-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
   Show/Hide
C29H32N8O2
 1
1
IC50 = 46000 nM
   TI
   LI
   LO
   TS
CP0237594
N-[5-[[5-chloro-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
   Show/Hide
C28H32ClN7O2
 1
1
IC50 = 58000 nM
   TI
   LI
   LO
   TS
CP0362792
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[5-methyl-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
   Show/Hide
C29H35N7O2
 1
1
IC50 = 71000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0065750
1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl]urea
   Show/Hide
C19H12ClF3N6O2  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0068244
(3R)-3-methyl-4-[6-(1-methylsulfonylcyclopropyl)-2-(1H-pyrrolo[2,3-c]pyridin-4-yl)pyrimidin-4-yl]morpholine
   Show/Hide
C20H23N5O3S  1
1
GI50 = 56 nM
   TI
   LI
   LO
   TS
CP0071106
N-[4-[2-(4-sulfamoylanilino)pyrimidin-4-yl]phenyl]-2-thiophen-2-ylacetamide
   Show/Hide
C22H19N5O3S2  1
1
IC50 = 250 nM
   TI
   LI
   LO
   TS
CP0086818
ethyl 7-[3-[[3-(trifluoromethyl)benzoyl]amino]phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate
   Show/Hide
C23H17F3N4O3  1
1
IC50 = 3870 nM
   TI
   LI
   LO
   TS
CP0095541
4-(4-(5-methylthiophen-2-yl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C15H14N4O2S2  1
1
IC50 = 1660 nM
   TI
   LI
   LO
   TS
CP0128358
(3-(6-morpholino-9-(piperidin-4-yl)-9H-purin-2-yl)phenyl)methanol
   Show/Hide
C21H26N6O2  1
1
IC50 = 1870 nM
   TI
   LI
   LO
   TS
CP0133877
6-Methoxy-7-(3-morpholin-4-yl-propoxy)-4-(4-phenoxy-phenylamino)-quinoline-3-carbonitrile
   Show/Hide
C30H30N4O4  1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CP0158116
4-({3-Chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl}-amino)-7-[(1E)-4-(4-ethylpiperazin-1-yl)but-1-enyl]quinoline-3-carbonitrile
   Show/Hide
C30H32ClN7S  1
1
IC50 = 34 nM
   TI
   LI
   LO
   TS
CP0158759
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(2-hydroxyethyl)benzenesulfonamide
   Show/Hide
C18H18N4O3S2  1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0161707
4-(8-methoxy-5,6-dihydrobenzo[h]quinazolin-2-ylamino)benzenesulfonamide
   Show/Hide
C19H18N4O3S  1
1
IC50 = 750 nM
   TI
   LI
   LO
   TS
CP0212097
3,3-dimethyl-N-(4-(2-(4-sulfamoylphenylamino)pyrimidin-4-yl)phenyl)butanamide
   Show/Hide
C22H25N5O3S  1
1
IC50 = 790 nM
   TI
   LI
   LO
   TS
CP0214842
(3-(9-((1-benzylpiperidin-4-yl)methyl)-6-morpholino-9H-purin-2-yl)phenyl)methanol
   Show/Hide
C29H34N6O2  1
1
IC50 = 3077 nM
   TI
   LI
   LO
   TS
CP0215324
3-cyanoquinoline, 8
   Show/Hide
C28H29ClN6O3S  1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0249607
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(3-(dimethylamino)propyl)benzenesulfonamide
   Show/Hide
C21H25N5O2S2  1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0258967
N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]-2-thiophen-2-ylacetamide
   Show/Hide
C24H21N5O3S2  1
1
IC50 = 290 nM
   TI
   LI
   LO
   TS
CP0297470
4-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-d]pyrimidin-2-ylamino)-benzenesulfonamide
   Show/Hide
C19H18N4O2S  1
1
IC50 = 4180 nM
   TI
   LI
   LO
   TS
CP0302346
3-methyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)butanamide
   Show/Hide
C23H25N5O3S  1
1
IC50 = 380 nM
   TI
   LI
   LO
   TS
CP0315053
4-(4-(4-methoxyphenyl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C17H16N4O3S  1
1
IC50 = 2550 nM
   TI
   LI
   LO
   TS
CP0316313
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(2-(dimethylamino)ethyl)benzenesulfonamide
   Show/Hide
C20H23N5O2S2  1
1
IC50 = 680 nM
   TI
   LI
   LO
   TS
CP0361417
CHEMBL4563026
   Show/Hide
C33H34ClFN7O3  1
1
GI50 = 7300 nM
   TI
   LI
   LO
   TS
CP0639837
8-[2-methoxy-5-(4-methylpiperazin-1-yl)anilino]-1-methyl-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H28N8O2  1
1
IC50 = 78 nM
   TI
   LI
   LO
   TS
CP0878975
N-(4-(hydroxycarbamoyl)benzyl)-1-(2-methoxyphenyl)-N-propyl-9H-pyrido[3,4-b]indole-3-carboxamide
   Show/Hide
C30H28N4O4  1
1
IC50 = 5070 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Lymph node)
Cell Line Name Organism Disease
AN3-CA Homo sapiens (Human) Acanthosis nigricans--NCIt; C7359; Endometrial adenocarcinoma
A2058 Homo sapiens (Human) Amelanotic melanoma
LOX-IMVI Homo sapiens (Human) Amelanotic melanoma
SW620 Homo sapiens (Human) Colon adenocarcinoma
SW620/AD300 Homo sapiens (Human) Colon adenocarcinoma
SK-MEL-5 Homo sapiens (Human) Cutaneous melanoma
SU-DHL-5 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
HOC313 Homo sapiens (Human) Floor of mouth squamous cell carcinoma
HGC-27 Homo sapiens (Human) Gastric carcinoma
NUGC-4 Homo sapiens (Human) Gastric signet ring cell adenocarcinoma
NCI-H1993 Homo sapiens (Human) Lung adenocarcinoma
PC-9 Homo sapiens (Human) Lung adenocarcinoma
NCI-H838 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1568 Homo sapiens (Human) Lung adenocarcinoma
PC9-DRH Homo sapiens (Human) Lung adenocarcinoma
NCI-H2009 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1299 Homo sapiens (Human) Lung large cell carcinoma
NCI-H1155 Homo sapiens (Human) Lung large cell carcinoma
NCI-H292 Homo sapiens (Human) Lung mucoepidermoid carcinoma
HBL-2 [Human mantle cell lymphoma] Homo sapiens (Human) Mantle cell lymphoma
MNT-1 Homo sapiens (Human) Melanoma
JR8 Homo sapiens (Human) Melanoma
MM96L Homo sapiens (Human) Melanoma
WM3629 Homo sapiens (Human) Melanoma
L3.6pl Homo sapiens (Human) Pancreatic adenosquamous carcinoma
LNCaP Homo sapiens (Human) Prostate carcinoma
LAPC-4 Homo sapiens (Human) Prostate carcinoma
LNCaP-AR Homo sapiens (Human) Prostate carcinoma
LNCaP C4-2 Homo sapiens (Human) Prostate carcinoma
MR49F Homo sapiens (Human) Prostate carcinoma
LNCaP-hr Homo sapiens (Human) Prostate carcinoma
LNCap-ARR2PB-eGFP Homo sapiens (Human) Prostate carcinoma
Th17 Mus musculus (Mouse) -